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Ethnopharmacological relevance: Caesalpinia pyramidalis Tul. (Fabaceae) is a plant found in the North-
east of Brazil that is popularly used to treat inﬂammation. Acute pancreatitis (AP) is an inﬂammatory
disease for which abdominal pain is a relevant symptom. As there is no speciﬁc therapy for AP, we
investigated the effect of the ethanol extract from the inner bark of C. pyramidalis (EECp) on the AP
induced by common bile duct obstruction (CBDO) in rats.
Material and methods: AP was induced in male Wistar rats (200–250g, n¼6–8) through laparotomy and
subsequent CBDO. Animals were euthanized after 6 (G6h) or 24 h (G24h) of induction. In the G6h
protocol, animals were pretreated with EECp (100–400 mg/kg, p.o.) or vehicle (Tween 80; 0.2%) 1 h
before CBDO or sham surgery. For the G24h protocol, rats were pretreated with EECp (400 mg/kg, 1 h
before CBDO or 1 h before and 12 h after CBDO) or vehicle. The following parameters were measured:
inﬂammatory/oxidative (myeloperoxidase activity and malondialdehyde formation in the pancreas and
lung, leukocyte counts in the blood and serum nitrate/nitrite), enzymatic (serum amylase and lipase
levels) and nociceptive (abdominal hyperalgesia).
Results: Induction of AP by CBDO signiﬁcantly increased all the parameters evaluated in both G6h and
G24h protocols when compared with the respective sham group. In the G6h protocol, the EECp
pretreatment (400 mg/kg) signiﬁcantly reduced all these parameters, besides completely inhibiting
abdominal hyperalgesia. The same proﬁle of reduction was observed from two administrations of EECp
in the G24h protocol, while one single dose of EECp was able to signiﬁcantly reduce pancreatic MDA,
serum lipase levels, leukocyte counts in the blood and abdominal hyperalgesia without affecting the
other parameters in the G24h protocol. Furthermore, rutin was found in the EECp.
Conclusions: Our results demonstrated that EECp decreases inﬂammation, lipoperoxidation and
hyperalgesia in CBDO-induced AP, making it of interest in future approaches to treat this condition.
& 2012 Elsevier Ireland Ltd. Open access under the Elsevier OA license.1. Introduction
Acute pancreatitis is an inﬂammatory disease caused mainly
by gallstones or abuse of alcohol (Wang et al., 2009). This disease
has an incidence varying from 5 to 80 per 100,000 inhabitants
(Abela and Carter, 2010) and a mortality rate that can reach 5%,pancreatitis; CBDO, common
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der the Elsevier OA license.depending on the severity (Pandol et al., 2007). The pathophy-
siology of acute pancreatitis is not completely understood and
involves many events and mediators that, along with the rapid
onset of this disease, frequently make the clinical management of
acute pancreatitis complicated (Bang et al., 2008). Although the
etiology of acute pancreatitis is still controversial, it is generally
accepted that an important initial event is the activation of
tripsinogen in the pancreatic acini (Frossard et al., 2008), followed
by activation of other enzymes (e.g., elastase and phospholipase
A2) and intrapancreatic inﬂammation caused by the production of
chemokines and leukocyte recruitment, besides pancreatic edema
(Bhatia et al., 2005). This process can spread out through the
activated pancreatic enzymes and mediators that reach the
circulation and consequently other tissues, leading to systemic
inﬂammation (Bhatia et al., 2000; Al Moﬂeh, 2008; Dios, 2010).
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which is one of the main complaints of patients (Liddle and
Nathan, 2004; Ceyhan et al., 2008) and is perceived as an
epigastric discomfort that can radiate to other regions (Vera-
Portocarrero and Westlund, 2005; Frossard et al., 2008).
The treatment of acute pancreatitis is still difﬁcult and usually
involves supportive therapy, prevention of infection, dissemination of
the inﬂammatory process and pain releif (Van Esch et al., 2006; Bang
et al., 2008). There is no speciﬁc pharmacological therapy for this
condition and a great need for new alternatives to treat acute
pancreatitis are undoubtedly of interest. Regarding this concern,
natural products have been throughout the decades a source of
substances with pharmacological potential, and in Brazil the ‘‘caa-
tinga’’ ecosystem is largely known for its biodiversity (Desmarchelier
et al., 1999; Albuquerque et al., 2007; Agra et al., 2008).
In this way, Caesalpinia pyramidalis Tul. (Fabaceae) is an endemic
tree of the Northeast region of Brazil that is known popularly as
‘‘catingueira’’ (Silva and Matos, 1998). Parts of this plant, especially
the inner bark or leaves, are traditionally used because of their anti-
inﬂammatory, dyspeptic, digestive, diuretic, antipyretic, and expec-
torant effects (Silva and Matos, 1998; Mendes et al., 2000; Bahia
et al., 2005; Agra et al., 2007). A common use of this plant is made
by macerating a handful of its stem bark in a liter of wine or
sugarcane brandy (locally known as ‘‘cachac-a’’), which is consumed
before meals, two times a day, for treating dysentery, diarrhea,
stomachache and other gastrointestinal diseases (Agra et al., 2008).
A previous study has shown that the ethanol extract of the
inner bark of this plant possesses anti-inﬂammatory and anti-
nociceptive activities by using models as carrageenan-induced
edema and peritonitis in rats and mice, respectively, as well as
acetic acid-induced abdominal writhing and formalin-induced
nociception in mice (Santos et al., 2011). Altogether, these ﬁnd-
ings suggest that C. pyramidalis has a potential for treating
inﬂammatory and painful conditions, particularly those involving
the gastrointestinal tract; it also has a potential for treating acute
pancreatitis.
In this study, we aimed to investigate the effect of the ethanol
extract from the inner bark of C. pyramidalis (EECp) in a model of
acute pancreatitis in rats. The use of EECp for inﬂammatory and
gastrointestinal disorders in popular medicine and previous data
conﬁrming the anti-inﬂammatory and antinociceptive properties
of this extract give basis to this hypothesis.2. Material and methods
2.1. Drugs and reagents
Rutin, apigenin, quercetin, baicalein, dexamethasone, hexade-
cyltrimethylammonium bromide, o-dianisidine hydrochloride,
nitrate reductase and cofactors, Griess reagent and Tu¨rk solution
were purchased from Sigma (USA). Morphine and diazepam were
obtained from Uni~ao Quı´mica (Brazil), and isoﬂurane (Isoforines)
was obtained from Crista´lia, Itapira, SP (Brazil). Other reagents
were obtained from Merck.
2.2. Plant material and preparation of the inner bark ethanol extract
The inner bark of Caesalpinia pyramidalis was collected at the
Xingo´ Village, Caninde´ de S~ao Francisco, Sergipe State, Brazil
(0916600000 S, 3717809400 W). A specimen was identiﬁed by the
botanist Dr. Ana Paula Nascimento Prata, Department of Biology
at the Federal University of Sergipe, and deposited in the Herbar-
ium of this institution (Marechal Rondon Av., S~ao Cristo´v~ao,
Sergipe, 49100–000, Brazil) under the registration number ASE
13,164. The inner bark was dried at 40 1C with forced air for 2 dayand subsequently powdered (2840g) and extracted by maceration
at room temperature with 90% ethanol for 5 day. The extract was
ﬁltered in vacuum, and the solvent was removed using a rotary
evaporator (45 1C). The percentage of EECp yield was 2.6% (73.8g).
2.3. High performance liquid chromatography-diode array detection
analysis
High performance liquid chromatography was performed with
a Shimadzu Liquid Chromatograph (Prominence model, Kyoto,
Japan) consisting of a vacuum degasser DGU-20A3 model, SIL-10A
autosampler, two high pressure pumps LC-6A, and an
SPDM20Avp photodiode array detector system coupled with a
CBM 20A interface. Data collection was carried out using LC
Solution software. Analysis was performed in an analytical
Phenomenex LUNAs C18 column (2504.6 mm i.d., 5 mm of
particle diameter, Torrance, CA, USA). Separation of compounds
was done by reverse mode gradient elution. The ﬂow rate was
1.0 mL/min, the volume injected was 20 mL, and a mobile phase
consisting of 0.5% aqueous formic acid (v/v, A) and acetonitrile
(B) was used in the following proportion: 30–63.3% (B) for 30 min,
40–100% for 5 min and 100% for 5 min. The photodiode array
detector was set at 254 nm for acquiring the chromatograms.
Samples of EECp or standards (rutin, apigenin, quercetin or
baicalein) were dissolved in methanol at concentrations of 5 and
0.1 mg/mL, respectively, and submitted to ﬁltration through a
cellulose membrane (pore diameter of 0.45 mm).
2.4. Animals
Male Wistar rats (220–270g) were obtained from the Animal
Center of the Federal University of Sergipe. Animals were main-
tained at 2172 1C with free access to food (Purinas) and ﬁltered
water under a 12:12 h light/dark cycle. The animals were
deprived of food for 8 h before the experiment, but had free
access to water. All experimental procedures were conducted in
accordance with the guidelines of the Brazilian College of Animal
Experimentation and were approved by the Ethics Committee for
Animal Use in Research at the Federal University of Sergipe
(protocol numbers 06/10 and 28/11), which was conducted in
accordance with the internationally accepted principles for
laboratory animal use and care. At the conclusion of the experi-
ments, animals were euthanized by overdose of isoﬂurane fol-
lowed by exsanguination.
2.5. Experimental procedure
Under anesthesia by inhalatory isoﬂurane (2–3%), acute pan-
creatitis was induced by common bile duct obstruction (CBDO), as
previously described by Samuel et al. (1994). This consisted of a
midline laparotomy through which the pancreas was exteriorized
by the duodenal loop in order to perform the common bile duct
ligation. For this purpose, two suture threads were wrapped
around the common bile duct, which was sutured in two posi-
tions with a distance of at least 0.5 cm between them, followed by
a small incision to assure that the duct ﬂow was obstructed.
Concomitantly, groups of animals underwent anesthesia, lapar-
otomy and exteriorization of the pancreas without obstruction of
the common bile duct as an experimental control (sham group).
The animals were euthanized after 6 or 24 h of the CBDO,
depending on the experimental protocol.
2.6. Experimental design
Nine experimental groups were used in this study. In the 6 h
protocol, 5 groups were considered: the group pretreated with
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undergoing only laparotomy and duct exposure (vehicleþsham
group; n¼6); the group pretreated with vehicle (1 h before) and
submitted to CBDO (vehicleþCBDO group; n¼8); and three
groups that were pretreated with EECp (100, 200 or 400 mg/kg,
p.o.) and submitted to CBDO (EECpþCBDO groups; n¼8 each).
The doses used in this study were based on a previous study from
our laboratory (Santos et al., 2011).
In the 24 h protocol, the animals were divided into 4 groups, as
follows. (i) vehicleþsham group: animals were pretreated with
vehicle (1 h before), submitted to laparotomy without duct
obstruction, and then received another administration of vehicle
(12 h after, p.o.; n¼6); (ii) vehicleþCBDO group: animals were
pretreated with vehicle (1 h before, p.o.), submitted to CBDO, and
then received another administration of vehicle (12 h after, p.o.;
n¼8); (iii) EECp (1 dose)þCBDO group: animals were pretreated
with EECp (400 mg/kg, 1 h before, p.o.), submitted to CBDO, and
subsequently administered vehicle (12 h after, p.o.; n¼6); and
(iv) EECp (2 doses)þCBDO group: animals were pretreated with
EECp (400 mg/kg, 1 h before, p.o.), submitted to CBDO, and
subsequently administered EECp again (400 mg/kg, 12 h after,
p.o.; n¼6). In these experiments, all rats were euthanized 24 h
after CBDO.
An additional group treated with morphine was considered in
the 24 h protocol, only for the measurement of abdominal
hyperalgesia (positive control). This group (n¼6) received mor-
phine at 5 mg/kg, i.p., 30 min before each measurement per-
formed at 6, 12 and 24 h (Vera-Portocarrero et al., 2003). As a
control of the inﬂammatory parameters, the groups of animals
were pretreated with dexamethasone (10 mg/kg, s.c.; n¼6) 1 h
before CBDO in the 6 h protocol, or 1 h before and 12 h after CBDO
in the 24 h protocol (n¼6).
After 6 or 24 h intervals, the animals were euthanized and
samples of pancreas, lung, liver and kidney were stored at 20 1C.
After collection, the blood was centrifuged at 1000 g for 15 min
at 4 1C to separate plasma that was then stored at 20 1C.
2.7. Measurement of abdominal hyperalgesia
To evaluate the mechanical hyperalgesia in the rat abdominal
region, we used the electronic von Frey (Insight, Ribeir~ao Preto,
S~ao Paulo, Brazil), according to previous description (Camargo
et al., 2011). The animals were transferred to individual cages and
acclimatized over 3 day by spending 30 min each day. On the day
of the test, mechanical stimuli were applied to the anterior-lateral
region of the abdomen of the animals, in triplicate, prior to any
manipulation and immediately before euthanasia for the 6 h
protocol or after 6, 12 or 24 h of CBDO for the 24 h protocol. At
each time point, an increasing stimulus (in g) was applied to the
abdominal region of the rats, with an interval of at least 1 min,
until any withdrawal behavior was observed, at which time the
threshold force value setting in the equipment (from 0.1 to
1000g) was registered. The test was performed ‘‘blind’’. Data were
expressed as variation (D) by subtracting the mean obtained from
the three measurements, taken at the referred to time point after
pancreatitis induction, from the mean basal value recorded for
each animal (prior to pancreatitis).
2.8. Determination of biochemical and inﬂammatory parameters
For myeloperoxidase activity (MPO) determination, pancreas
and lung samples were collected, weighed and homogenized with
potassium phosphate buffer (50 mM, pH 6.0 containing 0.5% of
hexadecyltrimethylammonium bromide), and 1-mL aliquots of
the homogenates were centrifuged (2 min, 8000 g, 4 1C). In a 96-
well plate, aliquots of supernatant were incubated with a solutionof o-dianisidine hydrochloride (0.167 mg/mL containing 0.005%
H2O2). The MPO activity was measured kinetically in a microliter
plate scanner (Labsystem Multiskan) at 460 nm and intervals of
15 s over a period of 5 min. Results were expressed as units of
MPO per mg tissue (UMPO/mg tissue). An UMPO was considered
as the amount of enzyme that degrades 1 mmol of hydrogen
peroxide/min (Bradley et al., 1982).
For determination of thiobarbituric acid reactive substances
(TBARS), samples of pancreas, lung, liver and kidney were
weighed and homogenized in potassium phosphate buffer
(50 mM, pH 7.4) containing butylated hydroxytoluene
(12.6 mM). Then, aliquots of the homogenate (in duplicate) were
incubated (90 1C, 45 min) with thiobarbituric acid (0.37%) in an
acidic solution (trichloroacetic acid at 15% and hydrochloric acid
at 0.25 N). At the end of incubation, the homogenates were
centrifuged (5 min, 8000 g), and aliquots from the supernatants
were extracted with n-butanol, followed by stirring in a vortex for
30 s and further centrifugation (2 min, 8000 g). The supernatant
absorbance was measured at 535 nm in a microplate reader
(corrected by the values of absorbance at 572 nm). The results
were calculated using a molar extinction coefﬁcient of
1.55105 M1 cm1 and expressed as nmol of malondialdehyde
(MDA) formed per mg of tissue (Bose et al., 1989).
The levels of amylase and lipase in serum were assessed for
each experimental group by using speciﬁc commercial kits for
kinetic determination of amylase (Katal Biotechnology, Belo
Horizonte, MG, Brazil) and a colorimetric kit for determination
of lipase (Human do Brasil, S~ao Paulo, SP, Brazil) according to the
manufacturers instructions.
The edema index was calculated as the ratio of wet weight and
dry weight of the samples of pancreatic tissue. For this purpose,
the samples were dried at 90 1C for 12 h, and tissue weight was
measured before and after this procedure.
Total and differential leukocyte counts were performed in
aliquots of 20 mL of peripheral blood taken from the tail vein of
anesthetized rats immediately before euthanasia. The total leu-
kocyte count was performed in a Neubauer chamber, and the
differential count was conducted under a light microscope with
immersion oil objective in cytocentrifuged smears colored with
Giemsa Newprovs, where 100 cells per slide were counted,
based on normal morphological criteria. Results were expressed
as number of leukocytes/mL of peripheral blood.
Total nitrate/nitrite (NOx
) concentration was determined in
serum submitted to ultraﬁltration (10 kDa; Microcon centrifugal
ﬁlter units) using the Griess reaction for nitrite, after the nitrate
reductase-catalyzed reduction of nitrate to nitrite, according to
Grisham et al. (1996).
2.9. Spontaneous locomotor activity
Rats were orally treated with vehicle or EECp (400 mg/kg) 1 h
before being introduced to the open ﬁeld apparatus, or with
diazepam (1.5 mg/kg, i.p.) 30 min before. The spontaneous loco-
motor activity of the animals was assessed in a circular open ﬁeld,
60 cm in diameter, over a period of 4 min (Capaz et al., 1981). This
procedure was repeated 6 h after the ﬁrst measurement (total
interval of 7 h between the administration of EECp and the second
measurement), and the values were expressed as the number of
ﬁeld crossings during the 4 min.
2.10. Statistical analysis
Results were expressed as mean7standard error of mean
(SEM) and analyzed by one-way analysis of variance (ANOVA)
followed by Tukey’s post hoc test by using GraphPad Prism
software (version 4.0). In the time course data for abdominal
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groups and treatments over all times, and if a signiﬁcant time vs.
treatment interaction was found, one-way ANOVA followed by
Tukey’s test was performed for each time to distinguish the effect
of the speciﬁc treatment. po0.05 was considered signiﬁcant.3. Results
3.1. Effect of EECp on serum amylase and lipase concentrations
As expected, the levels of serum amylase and lipase concentra-
tions were augmented after 6 h (po0.001 each) or 24 h (po0.001
each) of the CBDO when compared with the sham group (Fig. 1).
Previous administration of EECp at 200 or 400 mg/kg, but not at
100 mg/kg, signiﬁcantly decreased the serum amylase (po0.001 or
po0.01, respectively) after 6 h of CBDO when compared with the
vehicle group (Fig. 1A). In these same groups of animals, EECp (100–
400 mg/kg) also signiﬁcantly reduced the serum lipase (po0.05,
po0.01 or po0.01 for 100, 200 or 400 mg/kg, respectively; Fig. 1B).
Twenty-four hour after the CBDO, the previous treatment with
400 mg/kg of EECp reduced the amylase (po0.05) and lipase levels
(po0.01) when compared with the vehicle-treated group. In addi-
tion, two administrations of EECp signiﬁcantly reduced both serum
amylase and lipase (po0.01) levels when compared with the
respective vehicle-treated group (Fig. 1C and D). Treatment withFig. 1. The ethanol extract of the inner bark of Caesalpinia pyramidalis (EECp) reduces s
duct obstruction (CBDO)-induced pancreatitis. In panels A and C, rats were pretreated w
or vehicle, submitted to CBDO or sham surgery, and sacriﬁced 6 h after the obstructio
(1 dose) CBDO or 1 h before and 12 h after (2 doses) CBDO. In this case, when rats d
administered 1 h before and 12 h after CBDO. Rats were sacriﬁced 24 h after the obstru
or nnnpo0.001 vs. vehicleþCBDO (one-way ANOVA followed by Tukey’s test); n¼6–8dexamethasone reduced the circulating levels of amylase and lipase
in both the 6 and 24 h protocols (Fig. 1).3.2. Effect of EECp on MPO activity in pancreatic and lung tissue
The CBDO-induced pancreatic inﬂammation was characterized
by a marked increase of pancreatic MPO activity after 6 (po0.01)
or 24 h (po0.001) when compared with the respective sham
groups (Fig. 2A and B). The previous treatment with EECp at
400 mg/kg reverted this effect (po0.01) after 6 h of obstruction,
which was not observed at lower doses of this extract when
compared with animals pretreated with vehicle (Fig. 2A). Also,
two administrations of EECp (1 and 12 h) signiﬁcantly reduced
(po0.01) the pancreatic MPO activity after 24 h of induction.
Single pretreatment with EECp (1 h) did not modify this activity
(Fig. 2B). The treatment with dexamethasone (10 mg/kg) inhib-
ited the pancreatic MPO activity (po0.01) in both 6 (po0.05)
and 24 h (po0.01) protocol.
The induction of pancreatitis also signiﬁcantly increased MPO
activity in the lung tissue at both 6 (po0.01) and 24 h (po0.001)
when compared with the respective sham groups (Fig. 2C and D).
After 6 h of obstruction, the pretreatment with EECp (1 h), at
doses varying from 100 to 400 mg/kg, signiﬁcantly reduced the
lung MPO activity (Fig. 2C). Neither one nor two administrations
of EECp were able to alter MPO activity in lung tissue after 24 h of
the induction of pancreatitis (Fig. 2D). The treatment witherum amylase (A and B) and lipase (C and D) concentrations during common bile
ith EECp (100, 200 or 400 mg/kg; 1 h), dexamethasone (Dexa; 10 mg/kg; 1 h)
n. In panels B and D, EECp (400 mg/kg) was administrated to rats only 1 h before
id not receive EECp, they were given vehicle instead. Dexa (10 mg/kg) was also
ction. #po0.05, ##po0.01 or ###po0.001 vs. vehicleþsham; npo0.05, nnpo0.01
.
Fig. 2. Effect of the ethanol extract of the inner bark of Caesalpinia pyramidalis (EECp) on pancreatic and lung myeloperoxidase (MPO) activity. In panels A and C, rats were
pretreated with EECp (100, 200 or 400 mg/kg; 1 h), dexamethasone (Dexa, 10 mg/kg; 1 h) or vehicle, submitted to common bile duct obstruction (CBDO) or sham
surgery, and sacriﬁced 6 h after the obstruction. In panels B and D, EECp (400 mg/kg) was administrated to rats only 1 h before (1 dose) CBDO or 1 h before and 12 h after
(2 doses) CBDO. In this case, when rats did not receive EECp, they were given vehicle instead. Dexa (10 mg/kg) was also administered 1 h before and 12 h after CBDO. Rats
were sacriﬁced 24 h after the obstruction. MPO activity was measured in the pancreatic (A and B) and lung (C and D) tissues (n¼6–8 rats). ##po0.01 or ###po0.001 vs.
vehicleþsham; *po0.05,**po0.01 or ***po0.001 vs. vehicleþCBDO (one-way ANOVA followed by Tukey’s test).
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(po0.01) in both the 6 and 24 h protocols.
3.3. Effect of EECp on pancreatic edema
There was no signiﬁcant alteration of pancreatic edema after
6 h of vehicle treatment plus CBDO (4.670.3) when compared
with the sham group (3.770.3), and this was not modiﬁed by the
previous treatment with any dose of EECp used (3.870.3,
3.970.4 and 4.670.1 for 100, 200 and 400 mg/kg, respectively)
or dexamethasone (4.570.3). In contrast, after 24 h of the
induction of pancreatitis, a signiﬁcant increase in pancreatic
edema was observed (5.970.2, po0.01) when compared with
the sham group (4.470.2), which was reduced by two adminis-
trations of EECp at 400 mg/kg (4.570.1, po0.01), but not by one
single administration of this extract (5.170.2). Dexamethasone
at 10 mg/kg (2 doses) completely inhibited pancreatic edema
(3.770.2, po0.001).
3.4. Effect of EECp on circulating leukocyte counts
Associated with the induction of pancreatitis and investigation
of pancreatic and lung effects, the total and differential leukocyte
counts in the peripheral blood were evaluated as an additional
marker of systemic inﬂammation. In the experiments performed6 h after CBDO, we found a clear elevation of total leukocyte
counts (po0.001), which was caused by either increases in the
polymorphonuclear cell number (mostly neutrophils, po0.001)
or in the mononuclear cell number (monocytes and lymphocytes,
po0.001) when compared with the respective sham group, as
shown in Table 1. All doses of EECp (100–400 mg/kg) used in the
experiments conducted 6 h after CBDO, as well as any scheme of
treatment (one or two administrations) used in the experiments
conducted 24 h after CBDO, reduced the total and differential
leukocyte counts (po0.001; Table 1), as did dexamethasone,
when compared with the respective vehicle-treated group.
Experiments were performed in 6 or 24 h intervals of induc-
tion. In the 6 h interval, groups of animals were treated with EECp
(100, 200 or 400 mg/kg), dexamethasone (Dexa, 10 mg/kg) or
vehicle (Tween 80, 0.2% in saline) 1 h before they were submitted
to CBDO or sham surgery and sacriﬁced 6 h after the obstruction.
In the 24 h interval, EECp (400 mg/kg) was administrated to rats
only 1 h before (1 dose) CBDO or 1 h before and 12 h after
(2 doses) CBDO. In this case, when rats did not receive EECp,
they were given vehicle instead. Dexa (10 mg/kg) was also
administered 1 h before and 12 h after CBDO. Rats were sacriﬁced
24 h after the obstruction. Data are expressed as mean7SEM for
n¼6–8; one-way ANOVA followed by Tukey’s post test. apo0.001
vs. the respective shamþvehicle group or bpo0.001 vs. the
respective CBDOþvehicle group.
Table 1
The ethanol extract of Caesalpinia pyramidalis (EECp) reduces the total and differential leukocyte counts in the peripheral blood of rats







6 h ShamþVehicle 1.370.5 0.770.3 0.670.2
CBDOþVehicle 6.870.1a 4.970.3a 1.970.3a
CBDOþEECp (100 mg/kg) 2.370.1b 0.570.1b 0.870.1b
CBDOþEECp (200 mg/kg) 2.570.1b 1.670.1b 0.970.1b
CBDOþEECp (400 mg/kg) 2.670.2b 1.770.3b 0.970.2b
CBDOþDexa (10 mg/kg) 3.870.5b 2.270.4b 1.770.2
24 h ShamþVehicle 2.670.4 1.570.5 1.170.1
CBDOþVehicle 10.370.8a 4.870.6a 5.571.3a
CBDOþEECp (400 mg/kg, 1 dose) 6.071.9b 3.671.4b 2.470.6b
CBDOþEECp (400 mg/kg, 2 doses) 5.171.1b 2.570.4b 2.670.8b
CBDOþDexa (10 mg/kg) 2.370.3b 1.470.4b 0.970.1b
Experiments were performed in 6 or 24 h intervals of induction. In the 6 h interval, groups of animals were treated with EECp (100, 200 or
400 mg/kg), dexamethasone (Dexa, 10 mg/kg) or vehicle (Tween 80, 0.2% in saline) 1 h before they were submitted to CBDO or sham
surgery and sacriﬁced 6 h after the obstruction. In the 24 h interval, EECp (400 mg/kg) was administrated to rats only 1 h before (1 dose)
CBDO or 1 h before and 12 h after (2 doses) CBDO. In this case, when rats did not receive EECp, they were given vehicle instead. Dexa
(10 mg/kg) was also administered 1 h before and 12 h after CBDO. Rats were sacriﬁced 24 h after the obstruction. Data are expressed as
mean7SEM for n¼6–8; one-way ANOVA followed by Tukey’s post test.
a po0.001 vs. the respective shamþvehicle group or
b po0.001 vs. the respective CBDOþvehicle group.
Table 2
The ethanol extract from the inner bark of Caesalpinia pyramidalis (EECp)
decreases malondialdehyde (MDA) formation in pancreatic and lung tissues of





6 h ShamþVehicle 2678 2376
CBDOþVehicle 113715a 111710a
CBDOþEECp (100 mg/kg) 80717 8278
CBDOþEECp (200 mg/kg) 8876 72712
CBDOþEECp (400 mg/kg) 5575b 5574c
24 h ShamþVehicle 1772 1672
CBDOþVehicle 100712a 108717a
CBDOþEECp
(400 mg/kg, 1 dose)
3276c 3479c
CBDOþEECp
(400 mg/kg, 2 doses)
2475c 1771c
Experiments were performed at 6 or 24 h intervals from induction. In the 6 h
protocol, the groups of animals were treated with EECp (100, 200 or 400 mg/kg) or
vehicle (Tween 80, 0.2% in saline) 1 h before they were submitted to CBDO or
sham surgery, and then sacriﬁced 6 h after the obstruction. In the 24 h protocol,
EECp (400 mg/kg) was administrated to the rats only 1 h before CBDO (1 dose) or
1 h before and 12 h after CBDO (2 doses). In this case, when the rats did not
receive EECp, they were given vehicle instead. The rats were sacriﬁced 24 h after
the obstruction. Data are expressed as mean7SEM for n¼6–8; one-way ANOVA
followed by Tukey’s post test.
a po0.001 vs. the respective shamþvehicle group.
b po0.05 vs. the respective CBDOþvehicle group, or.
c po0.001 vs. the respective CBDOþvehicle group.
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Besides the increase in MPO activity, CBDO also induced lipid
peroxidation, detected through the increase of the formation of MDA
in both pancreas and lung tissues after 6 (po0.001) or 24 h
(po0.001; Table 2) when compared with the respective sham
groups. The administration of EECp (400 mg/kg) signiﬁcantly
decreased MDA formation in both the pancreas (po0.05) and lung
tissues (po0.001) after 6 h of CBDO when compared with the
vehicle-treated group (Table 2). After 24 h of CBDO, both the one-
and two-treatment schemes with EECp (400 mg/kg) diminished
MDA formation in the pancreatic tissue (po0.001; Table 2); how-
ever, MDA formation was signiﬁcantly decreased (po0.05) in lung
tissue only after two administrations of EECp (400 mg/kg; Table 2)
when compared with the vehicle-treated group. Dexamethasone
pretreatment did not alter the MDA formation in these tissues (data
not shown).
MDA formation in the liver and kidney was also investigated as a
marker of oxidative injury in these tissues. Neither the CBDO
induction nor the administration of EECp at any dose or scheme of
treatment used altered the MDA formation in these tissues (data not
shown).
Experiments were performed at 6 or 24 h intervals from induc-
tion. In the 6 h protocol, the groups of animals were treated with
EECp (100, 200 or 400 mg/kg) or vehicle (Tween 80, 0.2% in saline)
1 h before they were submitted to CBDO or sham surgery, and then
sacriﬁced 6 h after the obstruction. In the 24 h protocol, EECp
(400 mg/kg) was administrated to the rats only 1 h before CBDO
(1 dose) or 1 h before and 12 h after CBDO (2 doses). In this case,
when the rats did not receive EECp, they were given vehicle instead.
The rats were sacriﬁced 24 h after the obstruction. Data are
expressed as mean7SEM for n¼6–8; one-way ANOVA followed
by Tukey’s post test. apo0.001 vs. the respective shamþvehicle
group, bpo0.05 vs. the respective CBDOþvehicle group, or
cpo0.001 vs. the respective CBDOþvehicle group.
3.6. Effect of EECp on serum NOx
 concentration
Total serum NOx
 concentration was signiﬁcantly increased
(po0.01) in animals that were submitted to CBDO in the 6 h
protocol when compared with the sham group. The pretreatment
with EECp at 400 mg/kg, but not at lower doses, signiﬁcantlydecreased this effect (po0.05 vs. the vehicle-treated group;
Fig. 3A), as did dexamethasone (po0.05). Twenty-four h after CBDO,
the serum NOx
 concentration was also increased in animals with
pancreatitis (po0.01 vs. the sham group), which was signiﬁcantly
decreased (po0.05) by the treatment with two doses of EECp, but
not with one single treatment (Fig. 3B). Treatment with dexametha-
sone also decreased this concentration (po0.05, Fig. 3B).
3.7. Effect of EECp on mechanical abdominal hyperalgesia
CBDO also induced a marked abdominal hyperalgesia in rats
(Fig. 4) that was detected through the decreased intensity of
Fig. 3. The ethanol extract of the inner bark of Caesalpinia pyramidalis (EECp) reduces total nitrate/nitrite (NOx
) concentration during common bile duct obstruction
(CBDO)-induced pancreatitis. In panel A, rats were pretreated with EECp (100, 200 or 400 mg/kg; 1 h), dexamethasone (Dexa, 10 mg/kg; 1 h) or vehicle, submitted to
CBDO or sham surgery, and sacriﬁced 6 h after the obstruction. In panel B, EECp (400 mg/kg) was administrated to rats only 1 h before (1 dose) CBDO or 1 h before and 12 h
after (2 doses) CBDO. In this case, when rats did not receive EECp, they were given vehicle instead. Dexa (10 mg/kg) was also administered 1 h before and 12 h after CBDO.
The rats were sacriﬁced 24 h after the obstruction. ##po0.01 vs. vehicleþsham; *po0.05 vs. vehicleþCBDO (one-way ANOVA followed by Tukey’s test); n¼6–8.
Fig. 4. The ethanol extract from the inner bark of Caesalpinia pyramidalis (EECp)
inhibits abdominal hyperalgesia in common bile duct obstruction (CBDO)-induced
pancreatitis in rats. In panel A, rats were pretreated with EECp (100, 200 or
400 mg/kg; 1 h), morphine (0.5 h) or vehicle (Tween 80, 0.2% in saline),
submitted to CBDO or sham surgery, and then sacriﬁced 6 h after the obstruction.
In panel B, EECp (400 mg/kg) was administrated to rats only 1 h before CBDO
(1 dose) or 1 h before and 12 h after CBDO (2 doses). In this case, when rats did not
receive EECp, they were given vehicle instead. Morphine was given 0.5 h before
each measurement. The rats were sacriﬁced 24 h after the obstruction. The
threshold forces to cause withdrawal behavior were measured before (1 h)
and at 6 h (panel A), or at 6, 12 and 24 h (panel B), and the data are expressed as
the variation observed (g) for the intensity of stimulus for n¼6–8. ##po0.01 or
###po0.001 vs. the respective vehicleþsham; *po0.05, **po0.01, or ***po0.001
vs. the respective vehicleþCBDO. Panel A: one-way ANOVA followed by Tukey’s
test; Panel B: two-way ANOVA (po0.001 and F¼10.91) and one-way ANOVA
followed by Tukey’s test.
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(po0.01), 12 (po0.001) or 24 h when compared with the
respective sham group. Two-way ANOVA indicated a signiﬁcant
interaction between the time and treatment in this experiment
(po0.001; F¼10.91). The sham procedure did not alter the
withdrawal behavior of the rats (Fig. 4B).Fig. 4A demonstrated that pretreatment with EECp clearly
reduced the abdominal hyperalgesia of rats submitted to CBDO at
100 (po0.05), 200 or 400 mg/kg (po0.01) after 6 h of induction
when compared with the sham group. The experiments per-
formed at 24 h after CBDO have shown that a single previous
treatment of animals with EECp (400 mg/kg) maintained com-
plete reduction of abdominal hyperalgesia for the following 12 h
(po0.001 at each time evaluated, Fig. 4B) when compared with
the vehicle-treated group. Twenty-four hour after CBDO, animals
pretreated with this single dose of EECp still presented a sig-
niﬁcant reduction in hyperalgesia, although the variation of the
intensity of stimulus was signiﬁcantly different from the sham
group (po0.001). The administration of the second dose of EECp
(400 mg/kg) after 12 h of CBDO completely reduced the variation
of stimulus intensity applied to the abdominal region (po0.001
when compared with the groups that received only vehicle or
po0.01 when compared with the group that received the single
dose of EECp 1 h before CBDO). Treatment with morphine
signiﬁcantly reduced hyperalgesia (po0.001 for 6, 12 or 24 h)
when compared with the vehicle-treated group (Fig. 4).
3.8. Lack of effect of EECp on the locomotor activity of rats
One hour after the oral treatment of rats with EECp (400 mg/kg),
there was no change in the number of crossings in the open
ﬁeld apparatus (29.073.3) when compared with the vehicle-
treated group (32.870.9). In the same way, after 7 h of EECp
administration (6 h after the ﬁrst measurement), this extract did
not alter the number of crossings (16.871.7) when compared
with the vehicle-treated group (21.774.9). In contrast, the
treatment of animals with diazepam (1.5 mg/kg) signiﬁcantly
decreased the number of ﬁeld crossings by the animals after
30 min (12.073.5; po0.001) or 7 h (3.071.5; po0.01) when
compared with the groups treated with vehicle at 1 h or 7 h after,
respectively.
3.9. HPLC chromatographic analysis of EECp
EECp was submitted to HPLC chromatographic analysis for the
presence of ﬂavonoids because of the description in the literature
of high quantities of ﬂavonoids in the inner bark and/or leaves of
this plant (Silva et al., 2011). Fig. 5 shows a typical HPLC
chromatogram presenting at least 5 important peaks. The pre-
sence of rutin, apigenin, baicalein and quercetin was investigated
by comparing the retention time of EECp and the ﬂavonoids’
standard solutions, but only the retention time of the rutin
Fig. 5. Chromatograms of the ethanol extract of the inner bark of Caesalpinia pyramidalis (A) and authentic standard solution of rutin (B), quercetin (C), apigenin (D) and
baicalein (E) subjected to high performance liquid chromatography-diode array detection analysis set at 254 nm.
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This was conﬁrmed by the fortiﬁcation of the EECp with rutin and
the subsequent analysis, which showed a superposition of the
retention times of the peaks (not shown), indicating that rutin is
present in the EECp.4. Discussion
Treating acute pancreatitis is still a challenge to clinical
management because this disease is of rapid onset, the pancreas
is relatively inaccessible to physical examination, and in many
cases systemic inﬂammation adds complications to the patient’s
health (Pandol et al., 2007). The pharmacological treatment of this
disease requires new options in order to be improved, especially
for preventing systemic inﬂammation and treating abdominal
pain that are important characteristics of pancreatitis (Ceyhan
et al., 2008).
In this way, ethnopharmacological knowledge can be useful in
guiding the search for new compounds to treat pancreatitis. In
this study, we investigated the effect of the ethanol extract of a
plant derived from the Brazilian ‘‘caatinga’’ ecosystem. Parts of C.
pyramidalis are usually utilized by the population as a decoct to
treat various conditions, including gastrointestinal disorders
(Silva and Matos, 1998; Mendes et al., 2000; Bahia et al., 2005;
Agra et al., 2007; Agra et al., 2008), and the pharmacological
validation of this use has been published elsewhere (Santos et al.,
2011). The results obtained from the present study further
conﬁrm its traditional use by indicating that EECp exerts impor-
tant modulatory effects on acute pancreatitis in rats, suggesting
an innovative value for this extract and enabling future studies on
its components’ activities.
We chose CBDO as the model to induce pancreatitis in rats
because it mimics the pancreatitis induced in humans by lithiasis,
which is the main etiologic factor of this disease (Meyerholz et al.,
2008; Samuel et al., 2005). Thus, by using CBDO-induced pan-
creatitis, many signs commonly observed in patients can be
investigated. During the present study, pancreatitis induced by
CBDO was characterized by increased levels of pancreatic
enzymes in the blood, abdominal hyperalgesia, and pancreatic
neutrophil inﬁltration, edema and lipid peroxidation. We used
two experimental sets to investigate the effects of EECp in the
early (6 h) or late (24 h) periods after induction of pancreatitis.
This is justiﬁed based on the fact that in this model of pancreatitis
the source of the injury is induced surgically and is not reversible,which makes the local injury and systemic complications worse
at later times. After preliminary experiments, we found that a
single previous administration of EECp could be enough to reduce
some of the inﬂammatory/nociceptive parameters after 6 h of
CBDO. After performing experiments with the three doses of EECp
(100, 200 or 400 mg/kg), the 400 mg/kg dose was selected to
carry out the 24 h interval experiments. In these experiments,
both a single previous treatment (1 h) and a previous treatment
followed by another after 12 h of induction were compared to
analyze the inﬂammatory and nociceptive signs.
One of the hallmarks of pancreatitis is the elevation of amylase
and/or lipase in the blood (Forsmark and Baillie, 2007). In the
present study, CBDO increased both amylase and lipase levels
after 6 or 24 h of induction, which is in agreement with other
studies (Hirata et al., 2002; Barrett et al., 2008). It is interesting
that, while concentrations of amylase were lower at 24 h than at
6 h, the concentrations of lipase were maintained high through-
out both time periods considered. The increase in serum levels of
amylase usually precedes the increase in lipase levels, as well as it
decreases faster than lipase (Orebaugh, 1994; Shields et al., 2006).
Treatment with EECp was able to reduce both serum amylase and
lipase after 6 or 24 h of induction, in a similar way that
dexamethasone did, which indicates the potential of EECp to
reduce pancreatitis.
As a consequence of pancreatic enzyme activation in the acini,
local inﬂammatory response is developed, with characteristics
including edema and neutrophil inﬁltration. In the present study,
MPO activity was increased in pancreatic tissue after 6 or 24 h of
pancreatitis induction, which were reduced by EECp. This enzyme
activity is a common marker of neutrophil inﬁltration into the
tissues, as MPO is found in the azurophilic granules of neutrophils
(Bradley et al., 1982). This ﬁnding is consistent with the decrease
of neutrophil inﬁltration and the anti-inﬂammatory effect of
EECp. In addition, pancreatic edema was detected only at the
24 h time point, and the treatment with EECp was able to
decrease this effect, reinforcing its antiedematogenic activity, as
previously described (Santos et al., 2011).
Lung injury is the main secondary complication of acute
pancreatitis and the primary cause of death in patients (McKay
and Butter, 2003; Wang et al., 2009; Zhou et al., 2010). Lung
neutrophil inﬁltration was partially decreased by EECp after 6 h of
CBDO. However, after 24 h of CBDO, neither one single nor two
administrations of EECp were enough to reduce lung neutrophil
inﬁltration. There is no reasonable explanation for this fact, but
we must take into consideration that the pancreatic lesion is
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elevated the levels of pancreatic enzymes evaluated (and possibly
increased the levels of other enzymes like tripsin, phospholipase
A2 and elastase), which are believed to trigger lung injury (Al
Moﬂeh, 2008). As the effect of EECp on the levels of amylase and
lipase, after 24 h, was less effective than that detected after 6 h of
CBDO, it is possible to speculate on an association between these
two observations. Even though there are these considerations, the
results clearly demonstrated that EECp reduces pancreatic neu-
trophil inﬁltration, which may be of value for the treatment of
pancreatitis.
In addition, the increase of total leukocyte counts in the
peripheral blood in CBDO-induced pancreatitis was used as a
general sign of systemic inﬂammation and was caused by the
increases in both polymorphonuclear and mononuclear cells, as
previously observed by others (Dios et al., 2002; Yubero et al.,
2009; Ramudo et al., 2010). The leukocytosis induced by CBDO
was reduced by the treatment with EECp at all doses (100–
400 mg/kg) and schemes of treatment used here (one or two
administrations). This potential of EECp to decrease leukocyte
recruitment agrees with a study by Santos et al. (2011). These
authors reported that a previous treatment of rats with EECp
decreased paw edema and MPO activity induced by subplantar
injection of carrageenan. Also, they found that EECp reduced
leukocyte recruitment to the mouse peritoneal cavity induced
by carrageenan. These ﬁndings are in accordance with the data
from the present study, in the model of CBDO-induced pancrea-
titis in rats. The main difference between our study and the study
by Santos et al. (2011) is the fact that we used a model of
inﬂammation that brings a higher clinical value to the effect
observed, since pancreatitis can cause systemic inﬂammation that
resembles a condition observed in humans.
In the study by Santos et al. (2011), the authors suggested that
the anti-inﬂammatory effects of EECp could be related to the
in vitro antioxidant activity of this extract. In our study, this was
also taken into consideration, and the effect of EECp on in vivo
lipid peroxidation was investigated. In CBDO-induced pancreati-
tis, the inﬂammatory process might produce free radicals that in
turn cause lipoperoxidation, detectable through the formation of
the TBARS that generate MDA as the major aldehyde, a fact that
was observed in the pancreas and lung of animals in the present
study, concordant with previous ﬁndings (Sevillano et al., 2003;
Shi et al., 2005). In this regard, EECp decreased MDA formation in
the pancreatic and lung tissues. In the 6 h protocol, only the high
dose of EECp (400 mg/kg) was able to decrease MDA formation
after 6 h of pancreatitis induction, but maintained this effect until
24 h after CBDO, which was also observed for two administrations
of this ethanol extract. This indicates that EECp provided protec-
tion against the lipoperoxidation caused by CBDO, an observation
that completely agrees with prior ﬁndings that the aqueous
(Alviano et al., 2008) or ethanolic (Silva et al., 2011) extracts of
C. pyramidalis inner bark induce 2,2-diphenyl-1-picrylhydrazyl
(DPPH) consumption in vitro, a widely used antioxidant assay. In
agreement with the antioxidant and anti-inﬂammatory effects of
EECp, our results show that the production of NO was decreased
in animals treated with this extract, as NO metabolites were
detected at lower concentrations in the serum of these animals.
The inﬂammatory process and oxidative stress caused by
pancreatitis in rats closely resemble this condition in humans,
and EECp effectively decreased most of these alterations. How-
ever, another feature of clinical relevance in acute pancreatitis is
abdominal pain (Vera-Portocarrero and Westlund, 2005; Frossard
et al., 2008). Studying abdominal pain in CBDO-induced pancrea-
titis can be a difﬁcult task because this model of induction
involves a laparotomy. In spite of this complexity, a recent study
has shown that in the model of pancreatitis induced by commonbile duct injection of secretory phospholipase A2, which also
involves laparotomy, it is possible to detect an early abdominal
hyperalgesia after 4 h of the induction (Camargo et al., 2011). It is
interesting that these authors reported that the stimulation of the
abdominal region of rats that had received ductal saline injection
did not alter the intensity of stimulus necessary to induce a
withdrawal behavior. We observed a similar result in the present
study, where the sham group did not show any signiﬁcant
alteration of the withdrawal threshold. In contrast, animals
submitted to CBDO showed a time-dependent decrease of the
intensity of stimulus applied to the abdominal region during the
period of evaluation (0–24 h). It is worth pointing out that this is
the ﬁrst description of abdominal hyperalgesia for CBDO-induced
pancreatitis in literature. A previous single administration of EECp
(100–400 mg/kg) was able to inhibit abdominal hyperalgesia after
6 h of CBDO. Moreover, one single dose of 400 mg/kg completely
inhibited hyperalgesia after 12 h of obstruction and partially
reduced this phenomenon after 24 h. A second administration of
EECp after 12 h of CBDO totally reversed abdominal hyperalgesia
at the 24 h time point, an effect that was analogous to morphine.
It is worth mentioning that EECp induced an anti-hyperalgesic
effect even at the lower dose used, which did not adequately
reduce MPO activity in the pancreatic tissue. In the same way,
even with the lack of effect on pancreatic MPO activity after 24 h
of CBDO in animals pretreated with one single dose of EECp,
hyperalgesia was still reduced by this pretreatment. These obser-
vations indicate that EECp seems to have a more pronounced
anti-hyperalgesic than anti-inﬂammatory effect, or may have some
components able to affect nociceptive pathways. The mechanisms
underlying this effect are not understood, and further experiments
are necessary to elucidate these facts.
Furthermore, this anti-hyperalgesic effect of EECp is reinforced
by the ﬁndings of Santos et al. (2011). We observed that treat-
ment with EECp reduced the nociception induced by acetic acid
injection in the mouse abdominal region or formalin injection in
the mouse paw, which is consistent with an analgesic component
in this extract. As these effects could be affected by a possible
central action of EECp, experiments were performed with rats
treated or not with EECp in the open ﬁeld. Since no alteration of
the locomotor activity of rats was found with this apparatus, this
suggests that EECp does not cause central effects that could
interfere in the measurement of abdominal hyperalgesia, reinfor-
cing the results about the anti-hyperalgesic effects of EECp. This
observation is in conformity with the ﬁndings that EECp admin-
istration to mice, in the same dose range used in the present
study, did not change the performance of mice in the Rota-rod
test (Santos et al., 2011).
These actions of EECp might be caused by its components.
In this way, there are a number of compounds described in this
plant, and many of them are phenolic compounds, especially
ﬂavonoids (Mendes et al., 2000; Bahia et al., 2005, 2010; Silva
et al., 2011). The components of EECp are still unknown, and the
present study has suggested that rutin - but not apigenin (found
in the leaves of Caesapinia pyramidalis; Bahia et al., 2005),
quercetin or baicalein—is likely to be present in EECp. Future
studies are necessary to completely identify rutin and any other
components of this extract that may be of value in understanding
the effects of EECp. In the case of rutin, it was demonstrated that
this ﬂavonoid possesses anti-inﬂammatory, antioxidant and anti-
nociceptive effects that could account for the amelioration of
acute pancreatitis in rats, as observed in the present study. For
instance, rutin decreased paw edema induced by carrageenan and
arthritis induced by adjuvant plus carrageenan in rats (Guardia
et al., 2001; Rotelli et al., 2003). It also reduced nociception
induced by glutamate in mice paws (Lapa et al., 2009), renal
inﬂammation induced by cysplatin in rats (Arjumand et al., 2011)
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2011). These studies reinforce the possibility of rutin’s role in the
effects observed in CBDO-induced pancreatitis in rats.Conclusions
In summary, the present study demonstrated that EECp
decreased abdominal hyperalgesia and the local and systemic
inﬂammation that occur during CBDO-induced pancreatitis,
which further conﬁrms the anti-inﬂammatory and antinocicep-
tive activities of this extract. This ethanol extract is of great
interest as a source of novel molecules for developing strategies
more appropriate in treating pancreatitis. Future studies are
necessary in order to better identify the components of EECp
and the mechanisms underlying these activities.Acknowledgments
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